BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 28871935)

  • 1. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
    Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermoscopic Features of Giant Molluscum Contagiosum in a Patient with Acquired Immunodeficiency Syndrome.
    Sławińska M; Hlebowicz M; Iżycka-Świeszewska E; Sikorska M; Sokołowska-Wojdyło M; Smiatacz T; Gesing M; Nowicki RJ; Sobjanek M
    Acta Dermatovenerol Croat; 2020 Dec; 28(7):233-235. PubMed ID: 33834996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for cutaneous molluscum contagiosum.
    van der Wouden JC; van der Sande R; Kruithof EJ; Sollie A; van Suijlekom-Smit LW; Koning S
    Cochrane Database Syst Rev; 2017 May; 5(5):CD004767. PubMed ID: 28513067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molluscum Contagiosum: An Update.
    Leung AKC; Barankin B; Hon KLE
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):22-31. PubMed ID: 28521677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children.
    Arican O
    Pediatr Int; 2006 Aug; 48(4):403-5. PubMed ID: 16911087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience in treating molluscum contagiosum in children with imiquimod 5% cream.
    Bayerl C; Feller G; Goerdt S
    Br J Dermatol; 2003 Nov; 149 Suppl 66():25-9. PubMed ID: 14616342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod.
    Garland SM
    Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunocompromised woman with severe molluscum contagiosum that responded well to topical imiquimod: a case report and literature review.
    Lin HY; Linn G; Liu CB; Chen CJ; Yu KJ
    J Low Genit Tract Dis; 2010 Apr; 14(2):134-5. PubMed ID: 20354423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
    Ross GL; Orchard DC
    Australas J Dermatol; 2004 May; 45(2):100-2. PubMed ID: 15068455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
    Hengge UR; Cusini M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
    Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
    JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imiquimod as an immune response modulator in infectious conditions.
    Skinner RB
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod therapy for molluscum contagiosum.
    Liota E; Smith KJ; Buckley R; Menon P; Skelton H
    J Cutan Med Surg; 2000 Apr; 4(2):76-82. PubMed ID: 11179929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of molluscum contagiosum with imiquimod 5% cream.
    Skinner RB
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S221-4. PubMed ID: 12271282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of molluscum contagiosum with topical imiquimod in a severely immunocompromised HIV-positive patient.
    Strauss RM; Doyle EL; Mohsen AH; Green ST
    Int J STD AIDS; 2001 Apr; 12(4):264-6. PubMed ID: 11319979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on the efficacy, safety, and acceptability of imiquimod 5% cream versus cryotherapy for molluscum contagiosum in children.
    Al-Mutairi N; Al-Doukhi A; Al-Farag S; Al-Haddad A
    Pediatr Dermatol; 2010; 27(4):388-94. PubMed ID: 19804497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of molluscum contagiosum in children.
    Myhre PE; Levy ML; Eichenfield LF; Kolb VB; Fielder SL; Meng TC
    Pediatr Dermatol; 2008; 25(1):88-95. PubMed ID: 18304162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial.
    Theos AU; Cummins R; Silverberg NB; Paller AS
    Cutis; 2004 Aug; 74(2):134-8, 141-2. PubMed ID: 15379366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasiform eruption and oral ulcerations as adverse effects of topical 5% imiquimod treatment in children: a report of four cases.
    Smith WA; Siegel D; Lyon VB; Holland KE
    Pediatr Dermatol; 2013; 30(6):e157-60. PubMed ID: 22612595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molluscum contagiosum--a common but poorly understood "childhood disease" and sexually transmitted illness].
    Stock I
    Med Monatsschr Pharm; 2013 Aug; 36(8):282-90. PubMed ID: 23977728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.